Geron reported 47.85M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Amgen USD 6.17B 624M Jun/2025
Bio Techne USD 198.81M 15.74M Jun/2025
Cassava Sciences -5120000 22.82M Jun/2025
Cytokinetics 66.77M 165.03M Jun/2025
Exelixis USD 548.79M 12.52M Jun/2025
Genmab DKK 868M 195M Jun/2025
Geron 47.85M 9.45M Jun/2025
Gilead Sciences USD 5.58B 453M Jun/2025
Incyte USD 1.14B 151.67M Jun/2025
MacroGenics USD -27460000 41.32M Jun/2025
Novartis USD 11.51B 1.12B Jun/2025